<DOC>
	<DOCNO>NCT02024724</DOCNO>
	<brief_summary>Trigeminal neuralgia craniofacial pain syndrome typically characterized unilateral severe , recurrent , electrical pain one distribution trigeminal nerve . Current treatment strategy include oral medication first line therapy surgical intervention reserve patient refractory medication unable tolerate medication side effect . Despite current treatment option , many patient continue symptom . Ultrasound-guided trigeminal nerve block allow fine adjustment needle tip direct observation medicine . Local anesthetic steroid successfully use diagnostic therapeutic nerve pain great success . Steroids short long act duration vary side effect . If exists difference duration action , use longer acting drug provide great period symptom relief patient may allow patient undergo few interventional procedure .</brief_summary>
	<brief_title>Ultrasound Guided Trigeminal Nerve Block Typical Atypical Facial Pain</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<mesh_term>Facial Pain</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>All patient present Northwestern Pain Center eligible schedule receive ultrasoundguided trigeminal nerve block . Exclusion patient eligible ultrasound guide nerve block .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>